期刊
BIOMATERIALS
卷 34, 期 21, 页码 5359-5368出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2013.03.066
关键词
Sulforaphane; PLGA microspheres; Intra-articular injection; Osteoarthritis
资金
- National Research Foundation of Korea [2009-0092196]
- National Research Foundation of Korea [2009-0092196] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Sulforaphane (SFN) is a member of the isothiocyanate family that has anti-inflammatory action as well as anti-carcinogenic properties. The authors have devised an intra-articular injectable SFN PLGA microsphere system that can be used for treating osteoarthritis (OA). The purpose of this study was to evaluate the in vitro and in vivo efficacy of the SFN PLGA microsphere system. Articular chondrocytes were obtained from knee OA patients and were cultured in monolayers. The optimal concentration of SFN was obtained and the dose of SFN PLGA microspheres was determined based on the concentration. The in vitro anti-inflammatory effect on markers such as cyclooxygenase (COX)-2, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5, and matrix metalloproteinase (MMP)-2 was assessed by real-time PCR and Western blotting. The in vivo therapeutic effect of SFN PLGA microspheres was investigated using surgically-induced rat OA model. Treatment with SFN PLGA microspheres inhibited the mRNA and protein expression of COX-2, ADAMTS-5 and MMP-2 induced by LPS in articular chondrocytes. Intraarticular SFN PLGA microspheres delayed the progression of surgically-induced osteoarthritis in rats. In conclusion, SFN PLGA microspheres can be a useful injectable delivery system for treating osteoarthritis. (C) 2013 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据